Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
| unitaid [2022/03/05 00:04] pamela | unitaid [2022/03/05 01:40] (current) liam [Pandemic Corruption] | ||
|---|---|---|---|
| Line 33: | Line 33: | ||
| Interesting a " | Interesting a " | ||
| - | {{ :: | + | {{ :: |
| + | |||
| + | ==== TB Testing in Africa ==== | ||
| + | |||
| + | Given that TB is the leading cause of death among people living with HIV in Africa, greater access to the test will significantly boost the capacity of healthcare workers to reduce transmission of and premature deaths from the disease. The incremental scaling of the test in high-burden countries could enable the rapid diagnosis of seven hundred thousand cases of TB and save health systems more than $18 million in direct health costs. | ||
| + | |||
| + | "We are pleased to be working with the Bill & Melinda Gates Foundation, [[PEPFAR]], [[:USAID]], and UNITAID to make our innovative Xpert MTB/RIF test available for patient management in 145 HBDCs at less than $10 per test," said Cepheid CEO John Bishop. "As a result, every investment in [[GeneXpert]] technology in [HBDCs] will go further to identify patients with tuberculosis or drug-resistant tuberculosis, | ||
| + | |||
| + | ==== Pandemic Corruption ==== | ||
| + | Highwire - March 3, 2022 | ||
| + | Del Bigtree sits down for a one-on-one with the former W.H.O. consultant & research scientist, Tess Lawrie MD, PhD, who was a critical part of the [[: | ||
| + | |||
| + | Tess outlining UNITAID role derailing Ivermectin from 29 min. andconversations with Andrew Hill((https:// | ||
| + | |||
| + | |||
| + | === Andrew Hill's Ivermectin Problem === | ||
| + | |||
| + | Researcher Andrew Hill’s conflict: A $40 million Gates Foundation grant vs a half million human lives | ||
| + | Investigative Editor December 9, 2021 | ||
| + | |||
| + | by WorldTribune Staff, December 9, 2021 | ||
| + | |||
| + | In a stunning admission, virologist Dr. Andrew Hill acknowledged in a zoom call that publication of his study could lead to the deaths of at least a half million people. | ||
| + | |||
| + | In defending his reversal on the effectiveness of ivermectin as a treatment for COVID-19, he discussed his “difficult situation” and said, “I’ve got this role where I’m supposed to produce this paper and we’re in a very difficult, delicate balance.” | ||
| + | |||
| + | The incident is recounted in Robert Kennedy Jr’s New York Times Bestseller, The Real Anthony Fauci: Bill Gates, Big Pharma, and the global war on Democracy and Public Health. | ||
| + | |||
| + | Andrew Hill, PhD, is a senior visiting Research Fellow in Pharmacology at Liverpool University. He is also an advisor for the Bill and Melinda Gates Foundation and the Clinton Foundation. As a researcher for the WHO evaluating ivermectin, Hill wielded enormous influence over international guidance for the drug’s use. | ||
| + | |||
| + | Hill had previously authored a analysis of ivermectin as a treatment for COVID-19 that found the drug overwhelmingly effective. | ||
| + | |||
| + | On Jan. 6 of 2021, Hill testified enthusiastically before the NIH COVID-19 Treatment Guidlelines Panel in support of ivermectin’s use. Within a month, however, Hill found himself in what he describes as a “tricky situation.” Under pressure from his funding sponsors, Hill then published an unfavorable study. Ironically, he used the same sources as in the original study. Only the conclusions had changed. | ||
| + | |||
| + | Shortly before he published, Dr. [[Tess Lawrie]], Director of the Evidence-based Medicine Consultancy in Bath, England, and one of the world’s leading medical research analysts, contacted Hill via Zoom and recorded the call (transcript below). Lawrie had learned of his new position and reached out to try to rectify the situation. | ||
| + | |||
| + | In a remarkable exchange, a transcript of which appears on pages 137 – 143 in Kennedy’s book, Hill admitted his manipulated study would likely delay the uptake of ivermectin in the UK and United States, but said he hoped his doing so would only set the lifesaving drug’s acceptance back by about “six weeks,” after which he was willing to give his support for its use.((https:// | ||
| + | |||